28/06/2023
Today, EuropaBio’s General Assembly confirmed the appointment of Dr. Sarah Reisinger as the new Chair of the association. Sarah Reisinger is the Chief Science & Research Office at dsm-firmenich.
22/06/2023
EuropaBio is pleased to announce that bioMérieux has joined the association as Corporate Member.
bioMérieux is a family-owned biotechnology company founded in France. Since 1963, it has been at the forefront of ground-breaking advancements in the field of in vitro diagnostics, making significant contributions to improving public health worldwide. bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.
24/05/2023
EuropaBio is pleased to announce that SwedenBIO has joined as a National Association Council (NAC) member.
24/05/2023
EuropaBio is pleased to announce that Ajinomoto Europe has joined as a corporate member.
23/05/2023
Brussels, May 2023 – EuropaBio flies the flag for European biotechnology at the highly anticipated BIO International Convention 2023, scheduled to take place in Boston, MA on 5-8 June and one of the largest biotech industry events worldwide with 100+ interactive sessions across 4 days covering all aspects of business, policy, trade and science.
10/05/2023
EuropaBio invites you to register for the 16th edition of the European Forum for Industrial Biotechnology and the Bioeconomy organized together with local partners HollandBIO and ChemistryNL. On 24-25 October, EFIB brings you to cosmopolitan Rotterdam, at De Doelen ICC, a unique meeting place with a breathtaking view of the city center.
09/05/2023
Biomanufacturing is the use of biological mechanisms to i) synthesize products ii) act as tools or iii) undertake processes, at a scale required for commercial use.
09/05/2023
EuropaBio is pleased to announce that Dr Anne-Gaëlle Collot joins EuropaBio’s Industrial Biotechnology team as Industrial Biotechnology Director.
04/05/2023
On 27th April, EuropaBio organised a webinar to follow-up on the Biomanufacturing Policy Summit and officially release the policy recommendations resulting from the summit discussions and post-analysis. The outcome was a set of 10 policy recommendations that will be further developed by EuropaBio and shared in due course with policymakers and wider audience.
26/04/2023
A supportive and future-proof EU Pharmaceutical Legislation is critical to ensure that Europe can fully benefit from healthcare biotechnology innovations for patients, society, and economic development.
25/04/2023
On February 28th 2023, Rare Disease Day, EuropaBio's Small and Medium-sized Enterprises (SME) Platform hosted a session on rare diseases and invited European SMEs...
20/04/2023
EuropaBio is delighted to announce that 21st.BIO has joined as an Associate SME member.
20/04/2023
EuropaBio and its member AseBio, the Spanish Association of Biotechnology Companies, are delighted to invite you to the third National Associations Council (NAC) annual Presidency Summit.
16/03/2023
EuropaBio is pleased to announce that Disc Medicine has joined as a corporate member.
07/03/2023
EuropaBio is pleased to announce that Disc Medicine has joined as a corporate member.
01/03/2023
28/02/2023
EuropaBio Industrial Biotechnology Director Agnes Borg took part in the Swedish EU Council Bioeconomy conference. She presented on the importance of food as a key part of the bioeconomy
17/01/2023
17/01/2023
16/01/2023
